Karen A Nunley1, Christopher M Ryan1, Trevor J Orchard1, Howard J Aizenstein1, J Richard Jennings1, John Ryan1, Janice C Zgibor1, Robert M Boudreau1, Tina Costacou1, John D Maynard1, Rachel G Miller1, Caterina Rosano2. 1. From the Department of Epidemiology, Graduate School of Public Health (K.A.N., T.J.O., J.C.Z., R.M.B., T.C., R.G.M., C.R.) and Department of Psychiatry, School of Medicine (C.M.R., H.J.A., J.R.J., J.R.), University of Pittsburgh, Pittsburgh, PA; and VeraLight Inc. (J.D.M.), Albuquerque, NM. 2. From the Department of Epidemiology, Graduate School of Public Health (K.A.N., T.J.O., J.C.Z., R.M.B., T.C., R.G.M., C.R.) and Department of Psychiatry, School of Medicine (C.M.R., H.J.A., J.R.J., J.R.), University of Pittsburgh, Pittsburgh, PA; and VeraLight Inc. (J.D.M.), Albuquerque, NM. rosanoc@edc.pitt.edu.
Abstract
OBJECTIVE: Although microvascular complications are common in type 1 diabetes mellitus (T1DM), few studies have quantified the severity, risk factors, and implications of cerebral microvascular damage in these patients. As life expectancy in patients with T1DM increases, patients are exposed to age- and disease-related factors that may contribute to cerebral microvascular disease. METHODS: Severity and volume of white matter hyperintensities (WMH) and infarcts were quantified in 97 middle-aged patients with childhood-onset T1DM (mean age and duration: 50 and 41 years, respectively) and 81 non-T1DM adults (mean age: 48 years), concurrent with cognitive and health-related measures. RESULTS: Compared with non-T1DM participants, patients had more severe WMH (Fazekas scores 2 and 3 compared with Fazekas score 1, p < 0.0001) and slower information processing (digit symbol substitution, number correct: 65.7 ± 10.9 and 54.9 ± 13.6; pegboard, seconds: 66.0 ± 9.9 and 88.5 ± 34.2; both p < 0.0001) independent of age, education, or other factors. WMH were associated with slower information processing; adjusting for WMH attenuated the group differences in processing speed (13% for digit symbol, 11% for pegboard, both p ≤ 0.05). Among patients, prevalent neuropathies and smoking tripled the odds of high WMH burden, independent of age or disease duration. Associations between measures of blood pressure or hyperglycemia and WMH were not significant. CONCLUSIONS: Clinically relevant WMH are evident earlier among middle-aged patients with childhood-onset T1DM and are related to the slower information processing frequently observed in T1DM. Brain imaging in patients with T1DM who have cognitive difficulties, especially those with neuropathies, may help uncover cerebral microvascular damage. Longitudinal studies are warranted to fully characterize WMH development, risk factors, and long-term effects on cognition.
OBJECTIVE: Although microvascular complications are common in type 1 diabetes mellitus (T1DM), few studies have quantified the severity, risk factors, and implications of cerebral microvascular damage in these patients. As life expectancy in patients with T1DM increases, patients are exposed to age- and disease-related factors that may contribute to cerebral microvascular disease. METHODS: Severity and volume of white matter hyperintensities (WMH) and infarcts were quantified in 97 middle-aged patients with childhood-onset T1DM (mean age and duration: 50 and 41 years, respectively) and 81 non-T1DM adults (mean age: 48 years), concurrent with cognitive and health-related measures. RESULTS: Compared with non-T1DM participants, patients had more severe WMH (Fazekas scores 2 and 3 compared with Fazekas score 1, p < 0.0001) and slower information processing (digit symbol substitution, number correct: 65.7 ± 10.9 and 54.9 ± 13.6; pegboard, seconds: 66.0 ± 9.9 and 88.5 ± 34.2; both p < 0.0001) independent of age, education, or other factors. WMH were associated with slower information processing; adjusting for WMH attenuated the group differences in processing speed (13% for digit symbol, 11% for pegboard, both p ≤ 0.05). Among patients, prevalent neuropathies and smoking tripled the odds of high WMH burden, independent of age or disease duration. Associations between measures of blood pressure or hyperglycemia and WMH were not significant. CONCLUSIONS: Clinically relevant WMH are evident earlier among middle-aged patients with childhood-onset T1DM and are related to the slower information processing frequently observed in T1DM. Brain imaging in patients with T1DM who have cognitive difficulties, especially those with neuropathies, may help uncover cerebral microvascular damage. Longitudinal studies are warranted to fully characterize WMH development, risk factors, and long-term effects on cognition.
Authors: Augustina M A Brands; Roy P C Kessels; Roel P L M Hoogma; Johanna M L Henselmans; Johanna W van der Beek Boter; L Jaap Kappelle; Edward H F de Haan; Geert Jan Biessels Journal: Diabetes Date: 2006-06 Impact factor: 9.461
Authors: Caterina Rosano; Yue-Fang Chang; Lewis H Kuller; Jack M Guralnik; Stephanie A Studenski; Howard J Aizenstein; Peter J Gianaros; Oscar L Lopez; William T Longstreth; Anne B Newman Journal: Psychosom Med Date: 2013-07-25 Impact factor: 4.312
Authors: F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler Journal: J Neurol Neurosurg Psychiatry Date: 2001-01 Impact factor: 10.154
Authors: W T Longstreth; Alice M Arnold; Norman J Beauchamp; Teri A Manolio; David Lefkowitz; Charles Jungreis; Calvin H Hirsch; Daniel H O'Leary; Curt D Furberg Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: Terri H Lipman; Lorraine E Levitt Katz; Sarah J Ratcliffe; Kathryn M Murphy; Alexandra Aguilar; Iraj Rezvani; Carol J Howe; Shruti Fadia; Elizabeth Suarez Journal: Diabetes Care Date: 2013-01-22 Impact factor: 19.112
Authors: Y Xiong; Y Sui; Z Xu; Q Zhang; M M Karaman; K Cai; T M Anderson; W Zhu; J Wang; X J Zhou Journal: AJNR Am J Neuroradiol Date: 2016-03-17 Impact factor: 3.825
Authors: Karen A Nunley; Christopher M Ryan; Howard J Aizenstein; J Richard Jennings; Rebecca L MacCloud; Trevor J Orchard; Caterina Rosano Journal: Psychosom Med Date: 2017-06 Impact factor: 4.312
Authors: Christine M Embury; Alex I Wiesman; Amy L Proskovec; Elizabeth Heinrichs-Graham; Timothy J McDermott; Grace H Lord; Kaitlin L Brau; Andjela T Drincic; Cyrus V Desouza; Tony W Wilson Journal: Diabetes Date: 2018-03-12 Impact factor: 9.461
Authors: Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe Journal: J Neural Transm (Vienna) Date: 2017-08-01 Impact factor: 3.575
Authors: Karen A Nunley; Regina L Leckie; Trevor J Orchard; Tina Costacou; Howard J Aizenstein; J Richard Jennings; Kirk I Erickson; Caterina Rosano Journal: Neurology Date: 2017-03-10 Impact factor: 9.910
Authors: Ionut Bebu; Barbara H Braffett; Trevor J Orchard; Gayle M Lorenzi; David M Nathan; William H Herman; John M Lachin Journal: Diabetes Res Clin Pract Date: 2020-12-10 Impact factor: 5.602